We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares

144 hedge funds and large institutions have $2.61B invested in NovaBridge Biosciences American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 63 increasing their positions, 32 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 32

38% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 26

12% more call options, than puts

Call options by funds: $4.42M | Put options by funds: $3.97M

10% more capital invested

Capital invested by funds: $2.38B → $2.61B (+$239M)

6% more funds holding

Funds holding: 136144 (+8)

4.38% more ownership

Funds ownership: 15.99%20.37% (+4.4%)

43% less funds holding in top 10

Funds holding in top 10: 148 (-6)

Holders
144
Holders Change
+8
Holders Change %
+5.88%
% of All Funds
2.52%
Holding in Top 10
8
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-42.86%
% of All Funds
0.14%
New
36
Increased
63
Reduced
32
Closed
26
Calls
$4.42M
Puts
$3.97M
Net Calls
+$457K
Net Calls Change
-$1.26B
Name Holding Trade Value Shares
Change
Change in
Stake
N
51
Nuveen
North Carolina
$6.86M +$3.09M +42,700 +82%
UBS Group
52
UBS Group
Switzerland
$6.84M -$5.47M -75,692 -45%
Sumitomo Mitsui Trust Group
53
Sumitomo Mitsui Trust Group
Japan
$5.63M +$229K +3,163 +4%
QC
54
Quaero Capital
Switzerland
$5.52M
Swiss National Bank
55
Swiss National Bank
Switzerland
$5.32M
WBC
56
Westpac Banking Corp
Australia
$5.31M +$5.3M +73,224 New
DWA
57
Dorsey Wright & Associates
California
$5.07M +$5.05M +69,882 New
Northern Trust
58
Northern Trust
Illinois
$4.58M -$1.07M -14,793 -19%
Millennium Management
59
Millennium Management
New York
$4.24M +$2.36M +32,669 +126%
California Public Employees Retirement System
60
California Public Employees Retirement System
California
$4.06M +$4.05M +56,043 New
CS
61
Credit Suisse
Switzerland
$4M +$881K +12,187 +28%
Citadel Advisors
62
Citadel Advisors
Florida
$3.57M +$2.89M +40,018 +434%
AAF
63
Andra AP-fonden
Sweden
$3.15M +$593K +8,200 +23%
Acadian Asset Management
64
Acadian Asset Management
Massachusetts
$3.06M -$12.5M -172,360 -80%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$2.94M +$1.85M +25,556 +170%
GCM
66
Ghisallo Capital Management
Massachusetts
$2.72M +$2.71M +37,500 New
RCG
67
Rock Creek Group
District of Columbia
$2.61M +$1.16M +16,000 +80%
Invesco
68
Invesco
Georgia
$2.57M +$831K +11,486 +48%
Charles Schwab
69
Charles Schwab
California
$2.53M +$2.52M +34,860 New
Mirae Asset Global Investments
70
Mirae Asset Global Investments
South Korea
$2.47M +$2.21M +30,500 +864%
Korea Investment Corp
71
Korea Investment Corp
South Korea
$2.42M +$14.5K +200 +0.6%
CAM
72
CIF Asset Management
Hong Kong
$2.37M
PPA
73
Parametric Portfolio Associates
Washington
$2.32M +$1.23M +16,978 +113%
Bank of New York Mellon
74
Bank of New York Mellon
New York
$2.05M
JP Morgan Chase
75
JP Morgan Chase
New York
$1.91M -$8.97M -124,008 -83%

NBP Hedge Fund Activity: Q3 2021 in Review

144 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2021, worth a combined $2.61B — up 10% from $2.38B a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new NBP positions and 26 closed out — a net gain of 10 holders — while 63 added to existing stakes and 32 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $292M. The largest seller was WFM Asia, exiting entirely with an estimated $150M sold.

  • 144 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2021, up from 136 in Q2 2021.
  • Funds reported $2.61B of NovaBridge Biosciences American Depositary Shares stock for Q3 2021, up 10% quarter-over-quarter.
  • 36 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2021 and 26 closed out, a net change of +10 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2021 was T. Rowe Price Associates, an estimated $292M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2021 was WFM Asia, an estimated $150M sold.

Based on aggregated 13F filings for Q3 2021.